BBP Stock Forecast and Price Target (BioShares Biotechnology Products Fund stock)

BBP Stock Trend

The fund lies the upper part of a wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $53.28 will firstly indicate a slower falling rate, but may be the first sign of a trend shift.

Given the current short-term trend, the fund is expected to fall -3.01% during the next 3 months and, with a 90% probability hold a price between $46.66 and $51.68 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

WARNING: Trend forecast is still in the development phase and should be used with caution. Some cases might produce unexpected results such as negative prices at the end of the trend.

Data

Date	Bottom	Mid	Top
2021-09-20	$48.08	$50.67	$53.26
2021-09-21	$48.05	$50.64	$53.23
2021-09-22	$48.03	$50.61	$53.20
2021-09-23	$48.00	$50.59	$53.18
2021-09-24	$47.97	$50.56	$53.15
2021-09-27	$47.95	$50.54	$53.12
2021-09-28	$47.92	$50.51	$53.10
2021-09-29	$47.89	$50.48	$53.07
2021-09-30	$47.87	$50.46	$53.05
2021-10-01	$47.84	$50.43	$53.02
2021-10-04	$47.82	$50.40	$52.99
2021-10-05	$47.79	$50.38	$52.97
2021-10-06	$47.76	$50.35	$52.94
2021-10-07	$47.74	$50.33	$52.91
2021-10-08	$47.71	$50.30	$52.89
2021-10-11	$47.69	$50.27	$52.86
2021-10-12	$47.66	$50.25	$52.84
2021-10-13	$47.63	$50.22	$52.81
2021-10-14	$47.61	$50.19	$52.78
2021-10-15	$47.58	$50.17	$52.76
2021-10-18	$47.55	$50.14	$52.73
2021-10-19	$47.53	$50.12	$52.70
2021-10-20	$47.50	$50.09	$52.68
2021-10-21	$47.48	$50.06	$52.65
2021-10-22	$47.45	$50.04	$52.63
2021-10-25	$47.42	$50.01	$52.60
2021-10-26	$47.40	$49.99	$52.57
2021-10-27	$47.37	$49.96	$52.55
2021-10-28	$47.34	$49.93	$52.52
2021-10-29	$47.32	$49.91	$52.50

About BioShares Biotechnology Products Fund

The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the BioShares Biotechnology Products Index. Under normal market conditions, the fund will invest not less than 80% of its total assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering or product can... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!